Surkti Singh Sehti, Gutwell GP-1 medications represent a genuine medical breakthrough in obesity management but breakthrough tools still require expert hands
Consultation Workflow: Train pharmacists to spend 510 minutes with every GLP-1 patient explaining medication timing, dosage escalation, and expected results
Expanding the Role of CGM in Non-Insulin Users The benefits of continuous glucose monitoring are well known, including reduced episodes of hypoglycemia, improved time in range, better A1c levels, and less glycemic variability
Imaeda says women tend to lose more weight on GLP1 medications than men
Certain insulin products, such as NovoLog and Tresiba, will be $35/month
However, semaglutide is a smaller molecule (31 amino acids versus 39 for tirzepatide) with a different fatty acid modification, which gives it a somewhat different degradation profile